2nd Annual Biosimilars & Biobetters Congress 2014
03 Apr 2014 - 04 Apr 2014
Over 400 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions
25 presentations, case studies and panel discussions focused on the
key issues in follow-on biologics development and commercialisation
2 interactive streams:
- Market Opportunities and Commercial Challenges
- Developing Biosimilars and Biobetters
14 pre-scheduled one to one meetings, exhibition and informal networking opportunities
Co-located with the 7th Annual Proteins & Antibodies Congress & the Peptides Congress Oxford Global are proud to present the Biosimilars & Biobetters Congress, taking place on 3-4 April 2014 at Novotel London West, UK.
The follow on biologics industry is
forecast to reach $8.8 billion by 2017. Our conference programme focuses
on the challenges, innovations and technologies that promise to put
this sector at the forefront of the pharmaceutical industry.
The 2nd Annual Biosimilars and Biobetters Congress features two streams:
Market Opportunities & Commercial Challenges:
In Stream 1, the meeting will address the most pressing challenges in
gaining access to emerging markets and branding biosimilars through a
series of cutting-edge conference presentations. Our boisimilars experts
will also debate how to overcome regulatory challenges, outsource
manufacturing and develop pricing strategies
Developing Biosimilars & Biobetters: Learn
more about current developments in clinical trials, including
pharmacovigilence and patient safety. Do not miss out on the chance to
discover innovative solutions for achieving quality by design,
demonstrating biosimilarity and addressing potency as well as the latest
insights into the regulatory requirements and trial design.
The Biosimilars & Biobetters Congress is part of the highly successful Oxford Global Proteins Series.